A Dose-escalation Study in Subjects With Advanced Malignancies

Clinical trial NCT01195311 · COMPLETED

Trial details

NCT number: NCT01195311
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors and Hematologic Malignancy

Start date: 2010-07-01
Primary completion: 2013-05-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.